Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin XR in Neuropathic Pain
NCT07712913Phase 3Recruiting
- Sponsor
- Brainfarma
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 3 trial of pregabalin in diabetic peripheral neuropathy (DPN), postherpetic neuralgia (PHN), sponsored by Brainfarma. Started Jun 2026; status: recruiting.
02
Drugs
pregabalin
03
Conditions
diabetic peripheral neuropathy (DPN)postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT07712913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07712913.